Intel
INTC
Oracle
ORCL
Netflix
NFLX
4
Meta Platforms
META
5
Apple
AAPL
US Stock MarketDetailed Quotes
VRDN Viridian Therapeutics
- 13.530
- +0.030+0.22%
Close Apr 28 16:00 ET
- 13.530
- 0.0000.00%
Post 16:20 ET
1.10BMarket Cap-4.41P/E (TTM)
13.960High13.270Low683.51KVolume13.400Open13.500Pre Close9.24MTurnover0.94%Turnover RatioLossP/E (Static)81.48MShares27.20052wk High2.28P/B982.68MFloat Cap9.90052wk Low--Dividend TTM72.63MShs Float2247.750Historical High--Div YieldTTM5.11%Amplitude4.665Historical Low13.521Avg Price1Lot Size
About Viridian Therapeutics Company
Viridian Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of proprietary RNA-targeted therapeutics. Its product candidates include Cobomarsen, which treats patients with certain cancers, including cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma, and Remlarsen and MRG-229, which are made for the treatment of patients with pathological fibrosis. The company was founded by William S. Marshall and Bruce L. Booth in February 2006 and is headquartered in Waltham, MA.
Company Profile
SymbolVRDN
Company NameViridian Therapeutics
Listing DateJun 18, 2014
Issue Price10.00
Founded2006
CEOMr. Stephen Mahoney
MarketNASDAQ
Employees143
Fiscal Year Ends12-31
Address221 Crescent Street,Suite 401
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02453
Phone1-617-272-4600
Company Executives
- Name
- Position
- Salary
- Stephen Mahoney
- President, Chief Executive Officer and Director
- 12.48M
- Dr. Thomas Ciulla
- Chief Medical Officer
- --
- Jennifer Tousignant
- Chief Legal Officer
- --
- Thomas W. Beetham
- Chief Operating Officer
- 4.76M
- Seth Harmon
- Chief Financial Officer and Principal Accounting Officer
- 6.55M
- Tomas Kiselak
- Chairman of the Board
- 503.83K
- Dr. Christopher Cain, PhD
- Director
- --
- Jeffrey R. Ajer
- Director
- --
- Jennifer K. Moses
- Independent Director
- 467.83K
- Arlene M. Morris
- Independent Director
- 477.83K
- Dr. Sarah Gheuens, M.D.,PhD
- Independent Director
- 482.53K
Market Insights
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Trump 2.0 Era: How will global markets evolve?
🎙️Discussion: 1. How will tariff policies affect the movement of key assets such as U.S. stocks, gold, and Bitcoin? 2. Given this context,
Moo Live
Jan 23 16:54
MicroStrategy Q4 2024 earnings conference call